Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, Part 2: Influence of protocol-specific eligibility criteria on signal detection

Journal of Clinical Psychiatry

Volumn 73, Issue 11, 2012, Pages 1420-1425

  Sachs, Gary S ^a,b   Vanderburg, Douglas G ^c   Edman, Suzanne ^b   Karayal, Onur N ^c   Kolluri, Sheela ^c   Bachinsky, Mary ^c   Cavus, Idil ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Concordant Rater Systems ^*  (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; MOOD STABILIZER; PLACEBO; VALPROATE SEMISODIUM; ZIPRASIDONE;

ARTICLE; BIPOLAR I DISORDER; CLINICAL ASSESSMENT; COMPUTER PREDICTION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; DRUG TREATMENT FAILURE; HUMAN; INFORMATION RETRIEVAL; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MANIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIGNAL DETECTION; TREATMENT RESPONSE; YOUNG MANIA RATING SCALE;

EID: 84869220863     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.11m07389     Document Type: Article

References (11)

1. Sysko R, Walsh BT. A systematic review of placebo response in studies of bipolar mania. J Clin Psychiatry. 2007;68(8):1213-1217. doi:10.408/JCP.v68n0807 PubMed (Pubitemid 47395623)
2. Merlo-Pich E, Gomeni R. Model-based approach and signal detection theory to evaluate the performance of recruitment centers in clinical trials with antidepressant drugs. Clin Pharmacol Ther. 2008;84(3):378-384. doi:10.1038/clpt.208.70 PubMed
3. Merlo-Pich E, Alexander RC, Fava M, et al. A new populationenrichment strategy to improve efficiency of placebo-controlled clinical trials of antidepressant drugs. Clin Pharmacol Ther. 2010;88(5):634-642. doi:10.1038/clpt.2010.159 PubMed
4. Fava M, Evins AE, Dorer DJ, et al. The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach. Psychother Psychosom. 2003;72(3):115-127. doi:10.159/069738 PubMed (Pubitemid 36469860)
5. Quitkin FM, Petkova E, McGrath PJ, et al. When should a trial of fluoxetine for major depression be declared failed? Am J Psychiatry. 2003;160(4):734-740. doi:10.176/api.ajp.160.4.734 PubMed (Pubitemid 41079607)
6. Greist JH, Mundt JC, Kobak K. Factors contributing to failed trials of new agents: can technology prevent some problems? J Clin Psychiatry. 2002;63(suppl 2):8-13. PubMed (Pubitemid 34208791)
7. Sachs GS, Vanderburg DG, Karayal ON, et al. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, pt 1: results of a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2012;73(11):1412-1419.
8. Keck PE Jr, Versiani M, Potkin S, et al Ziprasidone in Mania Study Group. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Am J Psychiatry. 2003;160(4):741-748. doi:10.176/api.ajp.160.4.741 PubMed (Pubitemid 41079608)
9. Potkin SG, Keck PE Jr, Segal S, et al. Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial. J Clin Psychopharmacol. 2005;25(4):301-310. doi:10.1097/01.jcp.0169068.3432.70 PubMed (Pubitemid 41065070)
10. Reilly-Harrington NA, DeBonis D, Leon AC, et al. The interactive computer interview for mania. Bipolar Disord. 2010;12(5):521-527. doi:10.1/j.139-5618. 2010.084.x PubMed
11. Greist J, Mundt J, Jefferson J, et al. Comments on "why do clinical trials fail? the problem of measurement error in clinical trials: time to test new paradigms?" J Clin Psychopharmacol. 2007;27(5):535-537. doi:10.1097/JCP.0b013e31814f2c14 PubMed (Pubitemid 47415068)